Neonatal jaundice: Difference between revisions
No edit summary |
|||
Line 26: | Line 26: | ||
All [[jaundice]] should be medically evaluated before treatment can be given. | All [[jaundice]] should be medically evaluated before treatment can be given. | ||
==Epidemilogy and Demographics== | |||
This condition is common in newborns affecting over half (50 -60%) of all babies in the first week of life.<ref>{{Cite conference | |||
| title = Neonatal Jaundice | |||
| booktitle = Intensive Care Nursery House Staff Manual | |||
| publisher = UCSF Children's Hospital | |||
| date = 2004 | |||
| url = http://www.ucsfbenioffchildrens.org/pdf/manuals/41_Jaundice.pdf | |||
| accessdate = 26 July 2011}}</ref> | |||
==Causes== | ==Causes== | ||
Revision as of 15:37, 27 July 2012
For patient information, click here
Template:DiseaseDisorder infobox
WikiDoc Resources for Neonatal jaundice |
Articles |
---|
Most recent articles on Neonatal jaundice Most cited articles on Neonatal jaundice |
Media |
Powerpoint slides on Neonatal jaundice |
Evidence Based Medicine |
Cochrane Collaboration on Neonatal jaundice |
Clinical Trials |
Ongoing Trials on Neonatal jaundice at Clinical Trials.gov Trial results on Neonatal jaundice Clinical Trials on Neonatal jaundice at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Neonatal jaundice NICE Guidance on Neonatal jaundice
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Neonatal jaundice Discussion groups on Neonatal jaundice Patient Handouts on Neonatal jaundice Directions to Hospitals Treating Neonatal jaundice Risk calculators and risk factors for Neonatal jaundice
|
Healthcare Provider Resources |
Causes & Risk Factors for Neonatal jaundice |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Neonatal jaundice is a yellowing of the skin and other tissues of a newborn infant caused by increased levels of bilirubin in the blood.
A bilirubin level of more than 85 umol/l (5 mg/dL) manifests clinical jaundice in neonates whereas in adults a level of 34 umol/l (2 mg/dL) would look icteric. In newborns jaundice is detected by blanching the skin with digital pressure so that it reveals underlying skin and subcutaneous tissue. Jaundice newborns have an apparent icteric sclera, and yellowing of the face, extending down onto the chest.
In neonates the dermal icterus is first noted in the face and as the bilirubin level rises proceeds caudal to the trunk and then to the extremities.[1]
Neonatal jaundice can be physiological or pathological. Neonatal physiological jaundice is usually harmless: this condition is often seen in infants around the second day after birth, lasting until day 8 in normal births, or to around day 14 in premature births. Serum bilirubin normally drops to a low level without any intervention required: the jaundice is presumably a consequence of metabolic and physiological adjustments after birth. In extreme cases, a brain-damaging condition known as kernicterus can occur; there are concerns that this condition has been rising in recent years due to inadequate detection and treatment of neonatal hyperbilirubinemia. Neonatal jaundice is a risk factor for hearing loss.[2]
All jaundice should be medically evaluated before treatment can be given.
Epidemilogy and Demographics
This condition is common in newborns affecting over half (50 -60%) of all babies in the first week of life.[3]
Causes
In neonates, benign jaundice tends to develop because of two factors - the breakdown of fetal hemoglobin as it is replaced with adult hemoglobin and the relatively immature hepatic metabolic pathways which are unable to conjugate and so excrete bilirubin as fast as an adult. This causes an accumulation of bilirubin in the body (hyperbilirubinemia), leading to the symptoms of jaundice.
Severe neonatal jaundice may indicate the presence of other conditions contributing to the elevated bilirubin levels, of which there are a large variety of possibilities (see below). These should be detected or excluded as part of the differential diagnosis to prevent the development of complications. They can be grouped into the following categories:
Neonatal jaundice | |||||||||||||||||||||||||||||||||||||||||||||||
Unconjugated bilirubin | Conjugated bilirubin | ||||||||||||||||||||||||||||||||||||||||||||||
Pathologic | Physiologic | Hepatic | Post-hepatic | ||||||||||||||||||||||||||||||||||||||||||||
Hemolytic | Non-hemolytic | ||||||||||||||||||||||||||||||||||||||||||||||
Intrinsic causes | Extrinsic causes | ||||||||||||||||||||||||||||||||||||||||||||||
Intrinsic causes of hemolysis
- Membrane conditions
- Systemic contitions
- Enzyme conditions
- Glucose-6-phosphate dehydrogenase deficiency (also called G6PD deficiency)
- Pyruvate kinase deficiency
- Globin synthesis defect
Extrinsic causes of hemolysis
- Alloimmunity (The neonatal or cord blood gives a positive direct Coombs test and the maternal blood gives a positive indirect Coombs test)
Non-hemolytic causes
Hepatic causes
- Infections
- Metabolic
- Drugs
- Total parenteral nutrition
- Idiopathic
Post-hepatic
- Biliary atresia
- Bile duct obstruction
Breast feeding jaundice
"Breastfeeding jaundice" is caused by insufficient milk intake resulting in dehydration, and can be prevented by frequent breastfeeding sessions of sufficient duration to stimulate adequate milk production.
Breast milk jaundice
Very rarely, "breast milk jaundice" occurs during the second or third week of life, and may be caused by high levels of beta-glucuronidase in breast milk. Neither condition is a reason to stop nursing, though caregivers may advise IV or other fluid administration to ensure the baby is not dehydrated.
Natural history, Complications and Prognosis
Complications
With high doses of bilirubin (severe hyperbilirubinemia) there can be a complication known as kernicterus. This is the chief condition that treatment of jaundice is aimed at preventing. The effects of kernicterus range from fever, seizures, and a high-pitched crying to mental retardation. This is due to a staining effect on the basal ganglia leading to neuronal damage. With aggressive treatment such as exchange transfusion to lower very high bilirubin levels, the neurological effects are almost always transient.
Treatment
Infants with neonatal jaundice are often treated with bili lights, exposing them to high levels of colored light to break down the bilirubin. This works due to a photo oxidation process occurring on the bilirubin in the subcutaneous tissues of the neonate. Light energy creates isomerization of the bilirubin and consequently transformation into compounds that the new born can excrete via urine and stools. Blue light is typically used for this purpose. Green light is more effective at breaking down bilirubin, but is not commonly used because it makes the babies appear sickly, which is disturbing to observers. A recent study has shown that light therapy may increase the risk of skin moles (or "nevi") in childhood which in turn also increases the risk of melanoma (skin cancer).[4][5]
Brief exposure to indirect sunlight each day and increased feeding are also helpful. A newborn should not be exposed to direct sunlight because of the danger of sunburn, which is much more harmful to a newborn's thin skin than that of an adult.
If the neonatal jaundice does not clear up with simple phototherapy, other causes such as biliary atresia, PFIC, bile duct paucity, Alagille's syndrome, alpha 1 and other pediatric liver diseases should be considered. The evaluation for these will include blood work and a variety of diagnostic tests. Prolonged neonatal jaundice is serious and should be followed up promptly.
See also
References
- ↑ Madlon-Kay, Diane J. Recognition of the Presence and Severity of Newborn Jaundice by Parents, Nurses, Physicians, and Icterometer Pediatrics 1997 100: e3
- ↑ [http://aapnews.aappublications.org/cgi/content/full/18/5/231 "Increased vigilance needed to prevent kernicterus in newborns --O�Keefe 18 (5): 231 -- AAP News"]. Retrieved 2007-06-27. replacement character in
|title=
at position 66 (help) - ↑ "Neonatal Jaundice" (PDF). Intensive Care Nursery House Staff Manual. UCSF Children's Hospital. 2004. Retrieved 26 July 2011.
- ↑ [http://www.medpagetoday.com/HematologyOncology/SkinCancer/tb/4730 "Childhood Moles Linked to Neonatal Jaundice Treatment - CME Teaching Brief� - MedPage Today"]. Retrieved 2007-06-30. replacement character in
|title=
at position 75 (help) - ↑ "Infant Jaundice Treatment May Encourage Moles - Skin diseases, conditions and procedures on MedicineNet.com". Retrieved 2007-06-30.
Template:Certain conditions originating in the perinatal period Template:SIB de:Neugeborenengelbsucht